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Abstract
Background: Neuron specific enolase (NSE) has repeatedly been evaluated for neurological prognostication in
patients after cardiac arrest. However, it is unclear whether current guidelines for NSE cutoff levels also apply to
cardiac arrest patients treated with hypothermia. Thus, we investigated the prognostic significance of absolute NSE
levels and NSE kinetics in cardiac arrest patients treated with hypothermia.
Methods: In a prospective study of 35 patients resuscitated from cardiac arrest, NSE was measured daily for four
days following admission. Outcome was assessed at ICU discharge using the CPC score. All patients received
hypothermia treatment for 24 hours at 33°C with a surface cooling device according to current guidelines.
Results: The cutoff for absolute NSE levels in patients with unfavourable outcome (CPC 3-5) 72 hours after cardiac
arrest was 57 μg/l with an area under the curve (AUC) of 0.82 (sensitivity 47%, specificity 100%). The cutoff level for
NSE kinetics in patients with unfavourable outcome (CPC 3-5) was an absolute increase of 7.9 μg/l (AUC 0.78,
sensitivity 63%, specificity 100%) and a relative increase of 33.1% (AUC 0.803, sensitivity 67%, specificity 100%) at 48
hours compared to admission.
Conclusion: In cardiac arrest patients treated with hypothermia, prognostication of unfavourable outcome by NSE
kinetics between admission and 48 hours after resuscitation may be superior to prognostication by absolute NSE
levels.
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Background
The recommended examinations proposed by the Amer-
ican Academy of Neurology (AAN) for prognostication
in patients after cardiac arrest have mainly been evalu-
ated in the era prior to hypothermia [1]. However,
recent studies indicate that mild therapeutic hypother-
mia modifies the prognostic significance of clinical find-
ings, NSE levels, and electrophysiological testing in
patients resuscitated from cardiac arrest [2-6]. This has
generated the necessity to re-evaluate all prognostic
markers in patients treated with hypothermia. In parti-
cular, NSE cutoff levels and their temporal dynamics
have only rarely been investigated in these patients so
far. In this study, we prospectively investigated serum
NSE levels and NSE kinetics in 35 cardiac arrest patients
treated with hypothermia.
Methods
The study protocol was approved by the local ethics
committee on human research and was conducted in
accordance with the guidelines of the Declaration of
Helsinki. Written informed consent to the use of routine
clinical data is part of the standard contract between
patients and the University Hospital Charité Berlin and
was obtained from patients or their legal representatives.
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diac arrest were included in the study. All patients
received mild therapeutic hypothermia (MTH) irrespec-
tive of the initial cardiac rhythm. Baseline characteristics
of the patients are summarized in Table 1. Therapeutic
hypothermia was initiated immediately after admission
with an intravenous infusion of cold saline (4°C, 1000-
1500 ml bolus) followed by surface cooling with com-
mercially available non-invasive devices (ArcticSun2000
®
Medivance, USA). The target temperature (33°C) was
maintained for 24 hours. Intravenous sedation and
analgesia were induced in all patients by a combination
of midazolam (0.125 mg/kg/h) and fentanyl (0.002 mg/
kg/h) with dose adjustment as needed. In order to pre-
vent shivering, patients received muscle relaxation by
repetitive administration of pancuronium (0.1 mg/kg).
NSE serum levels were measured on admission and
daily until day four with an enzyme immunoassay
(Elecsys 2010, Roche Diagnostics GmbH, Mannheim,
Germany). None of the patients included in this study
received acute surgical interventions, implantation of
IABP or renal replacement therapy within the first three
days. In addition all blood samples underwent visual
inspection before testing to reduce the potential risk of
missing relevant haemolysis and to avoid false elevated
results of NSE. Clinical outcome was assessed at the
time of discharge from ICU by means of the Pittsburgh
cerebral performance category (CPC) [7]. All patients
were discharged directly to a neurological rehabilitation
facility. As in previous studies of outcome following car-
diac arrest, a CPC score of 1-2 was classified as favour-
able neurological outcome, whereas a CPC score of 3-5
was classified as unfavourable outcome. In detail the
categories define normal function (CPC 1) minor dis-
ability (CPC 2), severe disability (CPC 3), coma (CPC 4)
and death (CPC 5). NSE levels were determined in 35
patients at admission and then every 24 hours. Subse-
quently, the NSE dynamics between day one and day
three (absolute increase and percentage increase) was
analysed in 33 patients (data from two patients were
incomplete). The first sample was taken directly on
admission (direct admission to ICU from EMS), there-
fore the time between admission and second sample is
not exactly 24 hours as it is in all other time increments.
NSE levels were not blinded to the physicians in charge
but any decisions on therapy withdrawal were never
based on biochemical markers alone. Neurological
assessment was carried out by an external neurologist
and the decision to withhold or withdraw further thera-
pies was taken in all patients considering the results of
clinical signs, biochemical and electrophysiological
testing.
S i n c ed a t aw e r en o tn o r m a l l yd i s t r i b u t e d ,d e s c r i p t i v e
statistics were done by using medians and inter-quartile
ranges (IQR). The software Statistical Package for the
Social Sciences (SPSS Inc.; Chicago, Illinois) was used for
statistical analysis. Non-parametric test was used for
comparison of data. Sensitivities and specificities of dif-
ferent NSE thresholds for prediction of neurological out-
come were visualized by receiver operating curves (ROC).
Results
NSE levels on admission and at 24, 48 and 72 hours
Baseline characteristics of the study population are given
in Table 1. Cutoff values of absolute NSE level and NSE
kinetics obtained at different time points after cardiac
arrest are summarized in Table 2. For absolute NSE
levels, the highest predictive value was found for NSE at
48 hours with a cutoff level of 54.5 μg/l (specificity
100%, sensitivity 58%). At 72 hours, the cutoff level was
similar (57.2 μg/l), but sensitivity was markedly lower
(47%). Sensitivity was still lower for NSE levels on
admission and at 24 hours (8% and 30%, respectively;
Table 2). Median NSE levels were significantly lower
when adjusted for favourable outcome (CPC 1-2) and
unfavourable outcome (CPC 3-5) depending on the dif-
ferent time points of measurement after cardiac arrest
(p < 0.05; Figure 1).
NSE kinetics
The highest predictive value was found for a relative
increase in NSE of 33.1% between admission and at 48
Table 1 Baseline characteristics given as absolute
numbers and percent or median and interquartile range
(IQR).
Variable
Age (years) 63 (51-71)
Female sex 12 (43.3)
APACHE Score 28 (22-33)
Location of cardiac arrest
Out-of-hospital 28 (80)
In-hospital 7 (20)
Cause of cardiac arrest
AMI 16 (45.7)
Primary arrhythmia 10 (28.6)
Respiratory 9 (25.7)
Shockable rhythm 15 (42.9)
Time to ROSC (min) 19 (12-30)
Total epinephrine dose (mg) 2.5 (1.5-5)
Length of ICU stay (days) 7 (4-22)
Time on ventilator (hours) 161 (116-519)
Neurological outcome
CPC 1-2 11 (31.5)
CPC 3-5 24 (68.6)
APACHE: Acute Physiology and Chronic Health Evaluation, AMI: acute
myocardial infarction, ROSC: return of spontaneous circulation, ICU: intensive
care unit, CPC: cerebral performance category.
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dictive value was obtained for an absolute increase in
NSE between admission and at 48 hours with a cutoff
level of 7.9 μg/l (specificity 100%, sensitivity 63%). The
predictive value of the difference between NSE levels at
24 and 72 hours was markedly lower (sensitivity 37% for
absolute and 42% for relative increase) as well as for the
difference between 24 and 48 hours (sensitivity 39% for
absolute and 43% for relative increase; Figure 2). Cutoff
v a l u e sa n da r e au n d e rt h ec u r v e( A U C )f o rN S El e v e l
changes (absolute and percentage) are presented in
Table 2.
Discussion
Prognostication of outcome in cardiac arrest survivors
treated with hypothermia may be different from non-
hypothermia treated patients [2,3,8]. Accordingly, recent
data suggest that guideline NSE thresholds for outcome
prediction need to be re-evaluated in patients treated with
hypothermia. Our results indicate that in these patients,
repeated NSE measurements and calculation of NSE
kinetics may be superior compared to absolute NSE levels
determined on day one, two or three after cardiac arrest,
as recommended in the current guidelines of the Ameri-
can Academy of Neurology [1]. Instead, reliable outcome
prediction by repeated NSE measurements appears to be
possible as early as 48 hours after cardiac arrest.
In a sample of 97 patients, we have previously shown
that individual patients may survive with good neurolo-
gical outcome despite NSE levels of up to 80 μg/l mea-
sured 72 h after cardiac arrest. The greatest therapeutic
effect of hypothermia was observed in patients with
NSE levels between 20 and 80 μg/l, whereas in patients
with high (> 80 μg/l) or low (< 20 μg/l) NSE levels the
effect was smaller [2]. In a recent study by Daubin and
colleagues an even higher cutoff of 97 μg/l was discov-
ered for prediction of unfavourable outcome [5]. In the
present study, the sample is smaller and consists of 35
patients, eleven of which had a favourable outcome.
Therefore, the cutoff levels obtained must be interpreted
with caution and may be higher in individual subjects.
In a sub-analysis of the HACA trial, Tiainen and collea-
gues analyzed the effect of therapeutic hypothermia on
serum NSE levels 24, 36 and 48 hours after cardiac
arrest [9]. NSE levels were significantly lower in patients
treated with hypothermia. After 24 hours, the NSE cut-
off for prognostication of unfavourable outcome was
31.2 μg/l (specificity 96%, sensitivity 22%, AUC 0.72). At
48 hours, median NSE level in the hypothermia group
was only slightly lower compared to the control group
(median 7.9 μg/l and 8.6 μg/l; respectively). The 48
hours NSE cutoff for prognostication of unfavourable
outcome was 25.0 μg/l (specificity 96%, sensitivity 25%,
AUC 0.80). Current results by Mörtberg et al. conflict
with other studies, in that protein S-100 was superior to
NSE at all points of measurement (1, 2, 6, 12, 24, 48
and 96 hours) in predicting poor outcome, and peak
sensitivity of S-100 was very early after 24 hours (87%
sensitivity, 100% specificity) [10]. The authors interpret
their novel data with care due to small sample size but
argue that compared to other trials all types of rhythms
have been included in their analysis.
Compared to these data, our analysis for prognostica-
tion of unfavourable outcome revealed a higher sensitiv-
ity and a greater AUC especially for the NSE increase
from admission to 48 hours. Furthermore, a trend
towards a reduced discriminatory power of serum NSE
levels for unfavourable neurological outcome under
hypothermia treatment was found by Tiainen et al. with
an AUC of 0.89 in the control group compared to an
AUC of 0.80 in patients treated with hypothermia [9].
This may suggest that the relationship between NSE and
neurological outcome is indeed modified by hypother-
mia treatment.
Table 2 AUC values and cutoff values with 100% specificity for prognostication of unfavourable outcome.
NSE (hours) cutoff (μg/l) specificity % sensitivity % AUC 95% CI
0 75.5 100 8 0.614 0.41-0.82
24 73.6 100 30 0.804 0.65-0.96
48 54.5 100 58 0.848 0.72-0.98
72 57.2 100 47 0.824 0.67-0.98
absolute difference (increase)
0/48 7.9 100 63 0.784 0.63-0.93
24/48 25.1 100 39 0.673 0.50-0.84
24/72 28.1 100 37 0.711 0.52-0.90
percentage difference (increase)
0/48 33.1 100 67 0.803 0.66-0.95
24/48 58.0 100 43 0.671 0.50-0.84
24/72 74.9 100 42 0.760 0.58-0.95
AUC: area under the curve, CI: confidence interval.
Storm et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20:6
http://www.sjtrem.com/content/20/1/6
Page 3 of 6Many different cutoff levels have been published so far
[5,11-15]. The comparability of absolute NSE values for
prediction of neurological outcome seems limited as
cutoffs are presumably affected by multiple factors
including time to NSE measurement, laboratory immu-
noassay, cause of cardiac arrest, in/out-of-hospital car-
diac arrest, time to ROSC and outcome definition. In
addition, the ideal time point for measurement of NSE
in patients treated with MTH for predicting outcome is
still unclear. The major limitation concerning compar-
ability of the different results is a lack of a gold standard
in NSE testing (best time; best and standardized labora-
tory method). This was addressed already by almost all
other authors and underlines the need for more data
towards prognostication with biomarkers before being
incorporated in the guidelines [10,16,17]. Finally the
possible influence of the cooling method (device con-
trolled vs. alternative methods), which might lead to a
different temperature performance, could possibly influ-
ence NSE kinetic as well.
However, our results indicate that a serial measure-
ment might be a better predictor for patients under-
going hypothermia treatment.
Our results suggest dynamic changes in NSE serum
levels after resuscitation. While the pathophysiological
mechanisms underlying NSE release with global cerebral
ischemia following cardiac arrest are not precisely
known, experimental studies of focal cerebral ischemia
suggest that NSE release may reflect several steps in
stroke evolution. A first peak is thought to reflect a
rapid NSE release out of the initially damaged tissue,
followed by a second peak reflecting secondary mechan-
isms of brain damage, ongoing neuronal cell death or
persistent disturbance of the blood-brain barrier
[11,12,18]. Dynamic changes of NSE serum levels in
patients after cardiac arrest may similarly reflect distinct
but overlapping mechanisms of neuronal damage that
may be differentially affected by hypothermia compared
to non-hypothermia treatment. It appears therefore pos-
sible that the well-characterized kinetics of serum NSE
Figure 1 Boxplots with median and percentiles (25/75) of serum NSE levels for favourable outcome (CPC 1-2, solid boxes) and
unfavourable outcome (CPC 3-5, dashed boxes) at different time points (p < 0.05).
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tively and qualitatively from the kinetics observed here
[1]. This may at least partly explain differences between
our observations and previous trials in larger samples of
non-hypothermia patients.
Our study has several limitations that need to be
addressed. In this pilot study the number of patients is
too small to make definite conclusions about reliable
outcome prediction with calculated NSE changes. In
addition the population studied is heterogeneous con-
cerning location of the occurrence of cardiac arrest and
initial rhythm. Results were obtained in a single center
and we did not collect data on neurological long-term
outcome. We nevertheless deem that this should not
put the central findings of our study in question, as it
has been shown that CPC scores at ICU discharge
undergo only minor changes in the following six months
[13,19,20]. All survivors after cardiac arrest were dis-
charged from ICU directly to a neurological rehabilita-
tion facility; therefore the CPC used for analysis of the
group included in this study is the CPC at discharge
from hospital. Another important problem is the fact
that all studies on prognostication after cardiac arrest
are susceptible to “self-fulfilling prophecies”.I n d e e d ,i n
our study, NSE levels were not blinded to the physicians
in charge. However in our hospital, decisions on therapy
Figure 2 ROC analysis of NSE serum levels at different time points of measurement (absolute differences).
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alone. Neurological assessment was carried out by an
external neurologist and the decision to withhold or
withdraw further therapies was taken in all patients con-
sidering the results of clinical signs, biochemical and
electrophysiological testing. 11 out of 19 patients with
CPC 5 died after therapy withdrawal due to suspected
infaust prognosis.
Conclusion
Taken together, the findings in our study suggest that
serial measurement of serum NSE may be superior to
measurement at a single time point. Determination of
NSE kinetics across a temporal window as short as 48
hours appears to provide reliable information on out-
come of cardiac arrest patients treated with hypother-
mia. Larger trials are needed to establish precise
prognostic cutoff levels for NSE kinetics. Until these
data are available, absolute NSE cutoff levels for prog-
nostication after cardiac arrest should be interpreted
with caution.
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